The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Neprilysin - Wikipedia
CardsJC: EMPEROR-Preserved Trial - Cardionerds Twitter Journal Club
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Sacubitril - Wikipedia
PharmaWiki - Sacubitril
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy | Circulation: Heart Failure
Frontiers | Neprilysin Inhibitors and Bradykinin
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition | Circulation
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial - The Lancet
Bio <-> Chem: Back-story on Novartis LCZ696 database links
Bio <-> Chem: Back-story on Novartis LCZ696 database links
Is Entresto good for the brain? - Abstract - Europe PMC
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure | NEJM